Page last updated: 2024-08-16

salmeterol xinafoate and Pneumonia

salmeterol xinafoate has been researched along with Pneumonia in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (35.00)	29.6817
2010's	11 (55.00)	24.3611
2020's	2 (10.00)	2.80

Authors

Authors	Studies
Avorn, J; Feldman, WB; Kesselheim, AS; Russo, M; Wang, SV	1
Chang, TY; Chien, JY; Dong, YH; Lin, FJ; Wu, CH	1
Gill, TM; Leo-Summers, LS; Van Ness, PH; Vaz Fragoso, CA	1
Goike, H; Janson, C; Johansson, G; Jörgensen, L; Larsson, K; Lisspers, KH; Ställberg, B; Stratelis, G	1
Cates, CJ; Poole, P; Welsh, EJ	2
Abbasnejad, M; Boskabady, MH; Gholamnezhad, Z; Hosseini, M; Khazdair, MR	1
Heires, AJ; Nordgren, TM; Poole, JA; Romberger, DJ; Toews, ML; West, WW; Wyatt, TA	1
Anderson, JA; Calverley, PM; Celli, B; Crim, C; Ferguson, GT; Jenkins, C; Jones, PW; Vestbo, J; Willits, LR; Yates, JC	1
Anderson, JA; Calverley, PM; Celli, B; Ferguson, GT; Jenkins, CR; Jones, PW; Vestbo, J; Willits, LR; Yates, JC	1
Brown, J; Davis, K; Mapel, D; Miller, D; Schum, M; Yood, M	1
Calverley, PMA; Hagan, G; Riley, JH; Seemungal, TAR; Stockley, RA; Wedzicha, JA; Willits, LR	1
Beeh, KM; Fabbri, LM; Glaab, T; Hederer, B; Rabe, KF; Rutten-van Mölken, MP; Schmidt, H; Vogelmeier, C	1
Edwards, SJ; Gray, J; Halpin, DM; Morais, J; Singh, D	1
Lasserson, TJ; Nannini, LJ; Poole, P	1
de Vos, AF; Florquin, S; Jansen, HM; Maris, NA; Pater, JM; van der Poll, T; van der Sluijs, KF	1
Altman, LC; Potter-Perigo, S; Tsoi, C; Wight, TN; Wilkinson, TS	1
Allegra, L; Ambrosetti, U; Piatti, G; Santus, P	1
Duerden, M	1
Calhoun, WJ; Hinton, KL; Kratzenberg, JJ	1

Reviews

4 review(s) available for salmeterol xinafoate and Pneumonia

Article	Year
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. The Cochrane database of systematic reviews, 2013, May-31, Issue:5 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Albuterol; Androstadienes; Bronchodilator Agents; Drug Therapy, Combination; Fluticasone; Humans; Patient Dropouts; Pneumonia; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2013
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. The Cochrane database of systematic reviews, 2010, May-12, Issue:5 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Androstadienes; Bronchodilator Agents; Drug Therapy, Combination; Fluticasone; Humans; Patient Dropouts; Pneumonia; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2010
Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. International journal of clinical practice, 2011, Volume: 65, Issue:7 Topics: Administration, Inhalation; Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Ethanolamines; Fluticasone; Formoterol Fumarate; Glucocorticoids; Humans; Pneumonia; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Sample Size	2011
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. The Cochrane database of systematic reviews, 2012, Sep-12, Issue:9 Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluticasone; Formoterol Fumarate; Humans; Nebulizers and Vaporizers; Pneumonia; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Salmeterol Xinafoate	2012

Trials

7 trial(s) available for salmeterol xinafoate and Pneumonia

Article	Year
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of internal medicine, 2023, Volume: 176, Issue:8 Topics: Administration, Inhalation; Adult; Androstadienes; Asthma; Bronchodilator Agents; Cohort Studies; Drug Combinations; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Pneumonia; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate	2023
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS). BMJ (Clinical research ed.), 2013, May-29, Volume: 346 Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Androstadienes; Budesonide; Cohort Studies; Ethanolamines; Fluticasone; Formoterol Fumarate; Glucocorticoids; Humans; Pneumonia; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate	2013
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. The European respiratory journal, 2009, Volume: 34, Issue:3 Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Bronchodilator Agents; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk Factors; Salmeterol Xinafoate	2009
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respiratory research, 2009, Jun-30, Volume: 10 Topics: Aged; Albuterol; Androstadienes; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Combinations; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Smoking	2009
Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest, 2011, Volume: 139, Issue:3 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aged; Albuterol; Androstadienes; Bronchodilator Agents; C-Reactive Protein; Double-Blind Method; Female; Fluticasone; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk Factors; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2011
Tiotropium versus salmeterol for the prevention of exacerbations of COPD. The New England journal of medicine, 2011, Mar-24, Volume: 364, Issue:12 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pneumonia; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2011
The effect of salmeterol on markers of airway inflammation following segmental allergen challenge. American journal of respiratory and critical care medicine, 2001, Volume: 163, Issue:4 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Analysis of Variance; Asthma; Biomarkers; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Pneumonia; Probability; Reference Values; Respiratory Function Tests; Salmeterol Xinafoate; Treatment Outcome	2001

Other Studies

9 other study(ies) available for salmeterol xinafoate and Pneumonia

Article	Year
Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β Chest, 2020, Volume: 157, Issue:5 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Beclomethasone; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Therapy, Combination; Female; Fluticasone; Formoterol Fumarate; Glucocorticoids; Humans; Male; Metered Dose Inhalers; Middle Aged; Pneumonia; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Salmeterol Xinafoate; Taiwan	2020
Re-evaluation of combination therapy in chronic obstructive pulmonary disease (COPD). Respiratory medicine, 2019, Volume: 151 Topics: Aged; Bronchodilator Agents; Cardiovascular Diseases; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Severity of Illness Index; Spirometry	2019
Effect of fluticasone and salmeterol on tracheal responsiveness to ovalbumin and lung inflammation, administrated during and after sensitization. TheScientificWorldJournal, 2014, Volume: 2014 Topics: Albuterol; Androstadienes; Animals; Fluticasone; Guinea Pigs; Organ Culture Techniques; Ovalbumin; Pneumonia; Random Allocation; Salmeterol Xinafoate; Trachea; Treatment Outcome	2014
β2-Adrenergic agonists attenuate organic dust-induced lung inflammation. American journal of physiology. Lung cellular and molecular physiology, 2016, 07-01, Volume: 311, Issue:1 Topics: Adrenergic beta-2 Receptor Agonists; Air Pollutants; Albuterol; Animals; Cell Line; Cytokines; Drug Evaluation, Preclinical; Dust; Humans; Male; Mice; Mice, Inbred C57BL; Pneumonia; Respiratory Mucosa; Salmeterol Xinafoate	2016
Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators. Primary care respiratory journal : journal of the General Practice Airways Group, 2010, Volume: 19, Issue:2 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Case-Control Studies; Delayed-Action Preparations; Drug Therapy, Combination; Female; Fluticasone; Humans; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk Factors; Salmeterol Xinafoate; Severity of Illness Index	2010
Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice. American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:6 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Bronchodilator Agents; CD11b Antigen; Chemotaxis, Leukocyte; Female; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Pulmonary Alveoli; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Tumor Necrosis Factor-alpha	2004
Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. American journal of respiratory cell and molecular biology, 2004, Volume: 31, Issue:1 Topics: Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchi; Cells, Cultured; Cytokines; Drug Interactions; Fibroblasts; Fluticasone; Glucosamine; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Inflammation Mediators; Interleukin-1; Lung; Pneumonia; RNA, Messenger; Salmeterol Xinafoate; Th1 Cells; Th2 Cells; Transferases; Tumor Necrosis Factor-alpha	2004
Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacological research, 2005, Volume: 51, Issue:2 Topics: Albuterol; Cilia; Community-Acquired Infections; Female; Humans; Male; Mucus; Pneumonia; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate	2005
Prevention of death in COPD. The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21 Topics: Administration, Inhalation; Albuterol; Androstadienes; Bronchodilator Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Fluticasone; Humans; Pneumonia; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate	2007

chemdatabank.com